# Host iron deficiency protects against Plasmodium infection and drives parasite molecular reprofiling

**Authors:** Danielle Clucas, Cavan Bennett, Rebecca Harding, Anne Pettikiriarachchi, Andrew Baldi, Louise M. Randall, Ryan Steel, Ronan Mellin, Melissa Hobbs, Sabrina Caiazzo, Martin N. Mwangi, Katherine L. Fielding, Peter F. Hickey, Tracey M. Baldwin, Daniela Amann-Zalcenstein, Samantha J. Emery-Corbin, Glory Mzembe, Ernest Moya, Sabine Braat, Aaron Jex, Ayse Y. Demir, Hans Verhoef, Kamija S. Phiri, Beverley-Ann Biggs, Wai-Hong Tham, Justin A. Boddey, Sant-Rayn Pasricha, Ricardo Ataíde

PMC · DOI: 10.1126/sciadv.aeb0828 · Science Advances · 2026-02-27

## TL;DR

Iron deficiency in humans and mice reduces malaria severity and changes parasite biology, suggesting iron management is important in malaria-endemic regions.

## Contribution

This study demonstrates that iron deficiency protects against Plasmodium infection using clinical, genetic, and in vitro approaches.

## Key findings

- Iron deficiency in pregnant women was linked to a 50% reduction in P. falciparum parasitemia.
- Iron-deficient mice showed improved survival and resistance to cerebral malaria.
- Iron chelation altered the transcriptomic and proteomic profiles of P. falciparum parasites.

## Abstract

Iron deficiency, anemia, and Plasmodium infection are global health challenges with overlapping geographical distributions, particularly affecting pregnant women in Africa, yet the mechanisms underlying their interactions remain poorly understood. We used a multilayered approach combining clinical data from Malawian pregnant women (n = 711) in the REVAMP trial, a genetic mouse model [Tmprss6-knockout (KO)], and in vitro Plasmodium falciparum cultures to clarify iron-malaria associations. Iron deficiency was associated with 50% reduced P. falciparum parasitemia in pregnant women [95% CI (30 to 64%), P < 0.0001], while iron-deficient mice exhibited improved survival against P. berghei (median 15.5 days versus 7.0 days for WT mice) and protection from cerebral malaria (83% versus 17% survival). Iron chelation substantially changed the transcriptomic and proteomic profile of cultured P. falciparum parasites. Intravenous iron supplementation did not increase parasitemia when coupled with malaria prevention. These findings demonstrate that iron deficiency protects against Plasmodium infection and support World Health Organization recommendations for iron supplementation in malaria-endemic regions when combined with adequate malaria prevention strategies in place.

Iron deficiency across three different biological systems shows protection against malaria.

## Linked entities

- **Genes:** TMPRSS6 (transmembrane serine protease 6) [NCBI Gene 164656]
- **Diseases:** anemia (MONDO:0002280), cerebral malaria (MONDO:0005625)
- **Species:** Plasmodium falciparum (taxon 5833), Plasmodium berghei (taxon 5821), Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** TMPRSS6 (transmembrane serine protease 6) [NCBI Gene 164656] {aka IRIDA, MT2}, Crp (C-reactive protein, pentraxin-related) [NCBI Gene 12944], Hamp (hepcidin antimicrobial peptide) [NCBI Gene 84506] {aka Hamp1, Hepc, Hepc1}, Tmprss6 (transmembrane serine protease 6) [NCBI Gene 71753] {aka 1300008A22Rik}, Hdgfl2 (HDGF like 2) [NCBI Gene 15193] {aka HRP-2, Hdgfrp2}
- **Diseases:** Iron deficiency anemia (MESH:D018798), MS (MESH:C536030), ID (MESH:D000090463), hemolysis (MESH:D006461), splenomegaly (MESH:D013163), alopecia (MESH:D000505), RDT (MESH:D013736), P. falciparum parasitemia (OMIM:248310), P. falciparum (MESH:D016778), inflammation (MESH:D007249), inflamed (MESH:C531841), HIV (MESH:D015658), Malaria (MESH:D008288), restricted (MESH:D002313), liver infection (MESH:D017093), infected (MESH:D007239), P. berghei infection (MESH:D016720), weight loss (MESH:D015431), Parasitemia (MESH:D018512), paresis (MESH:D010291), cerebral malaria (MESH:D016779), anemia (MESH:D000740), death (MESH:D003643), deficient (MESH:D007153)
- **Chemicals:** dithiothreitol (MESH:D004229), sulfadoxine-pyrimethamine (MESH:C001205), ethanol (MESH:D000431), sorbitol (MESH:D013012), Iron (MESH:D007501), iodoacetamide (MESH:D007460), EDTA (MESH:D004492), xylazine (MESH:D014991), d-Luciferin (MESH:C532924), ACN (MESH:C032159), DFO (MESH:D003676), ferric carboxymaltose (MESH:C522335), PBS (MESH:D007854), heparin (MESH:D006493), AL (MESH:D000077611), saponin (MESH:D012503), FA (MESH:D005492), sucrose (MESH:D013395), cotrimoxazole (MESH:D015662), urea (MESH:D014508), trifluoroacetic acid (MESH:D014269), IPTp-SP (-)
- **Species:** Human immunodeficiency virus 1 (no rank) [taxon 11676], Mus musculus (house mouse, species) [taxon 10090], Plasmodium berghei (species) [taxon 5821], Plasmodium falciparum (malaria parasite P. falciparum, species) [taxon 5833], Plasmodium falciparum 3D7 (isolate) [taxon 36329], Homo sapiens (human, species) [taxon 9606], Anopheles stephensi (Asian malaria mosquito, species) [taxon 30069]
- **Cell lines:** 3D7 — Mus musculus (Mouse), Hybridoma (CVCL_KS87), /c — Mus musculus (Mouse), Hepatocellular carcinoma of the mouse, Cancer cell line (CVCL_9103)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12947883/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12947883/full.md

## References

79 references — full list in the complete paper: https://tomesphere.com/paper/PMC12947883/full.md

---
Source: https://tomesphere.com/paper/PMC12947883